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Exercise capacity and cardiac 
hemodynamic response in female 
ApoE/LDLR−/− mice: a paradox 
of preserved V’O2max and exercise 
capacity despite coronary 
atherosclerosis
M. Wojewoda1,*, U. Tyrankiewicz2,*, P. Gwozdz3, T. Skorka2, M. Jablonska2, A. Orzylowska2, 
K. Jasinski2, A. Jasztal1, K. Przyborowski1, R. B. Kostogrys4, J. A. Zoladz5 & S. Chlopicki1,3
We assessed exercise performance, coronary blood flow and cardiac reserve of female ApoE/LDLR−/− 
mice with advanced atherosclerosis compared with age-matched, wild-type C57BL6/J mice. Exercise 
capacity was assessed as whole body maximal oxygen consumption (V’O2max), maximum running 
velocity (vmax) and maximum distance (DISTmax) during treadmill exercise. Cardiac systolic and diastolic 
function in basal conditions and in response to dobutamine (mimicking exercise-induced cardiac stress) 
were assessed by Magnetic Resonance Imaging (MRI) in vivo. Function of coronary circulation was 
assessed in isolated perfused hearts. In female ApoE/LDLR−/− mice V’O2max, vmax and DISTmax were not 
impaired as compared with C57BL6/J mice. Cardiac function at rest and systolic and diastolic cardiac 
reserve were also preserved in female ApoE/LDLR−/− mice as evidenced by preserved fractional area 
change and similar fall in systolic and end diastolic area after dobutamine. Moreover, endothelium-
dependent responses of coronary circulation induced by bradykinin (Bk) and acetylcholine (ACh) 
were preserved, while endothelium-independent responses induced by NO-donors were augmented 
in female ApoE/LDLR−/− mice. Basal COX-2-dependent production of 6-keto-PGF1α was increased. 
Concluding, we suggest that robust compensatory mechanisms in coronary circulation involving PGI2- 
and NO-pathways may efficiently counterbalance coronary atherosclerosis-induced impairment in 
V’O2max and exercise capacity.
Atherosclerosis is a major cause of death worldwide (for review see)1. It is linked to development of endothelial 
dysfunction, lipid retention in subendothelial space of arteries and vascular inflammation that leads to intravas-
cular thrombosis and its clinical consequences such as coronary artery disease2. Atherosclerotic changes are not 
only present in disease states (i.e. coronary heart disease, peripheral arterial disease or type 2 diabetes), but also 
accompany physiological human aging and may be clinically silent for long periods of time3.
Atherosclerosis usually is associated with worse exercise capacity in men4–6. Furthermore, impaired exercise 
tolerance was reported to be a prognostic tool to predict the development of atherosclerotic changes in patients7–9. 
In single knockout ApoE−/− mice, representing the most frequently used murine model of spontaneous ath-
erosclerosis10, exercise capacity was also impaired compared to healthy mice11–14. Moreover, cardiac structure 
and function in ApoE−/− mice was altered15,16, including reduction of their cardiac contractility reserve after 
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dobutamine stimulation17. On the other hand, single knockout LDL−/− mice covered distances comparable to 
their wild-type counterparts when accommodated in cages equipped with wheels that suggested their everyday 
exercise capacity was not compromised (please compare daily covered distances in Lightfoot et al.18 and O’Bryan 
et al.19).
Double ApoE−/− and LDLR−/− knockouts constitute a reliable model of human atherosclerosis that displays 
some advantages over single ApoE−/− and LDLR−/− knockouts20,21. Namely, in ApoE/LDLR−/− mice plasma 
concentration of low density lipoprotein cholesterol fraction is very high, and spontaneous atherosclerosis 
develops more rapidly compared to ApoE−/− mice. Moreover, a western diet is not needed to induce athero-
sclerosis as in LDLR−/− mice. Furthermore, arterial plaques become advanced atherosclerotic plaques earlier 
and resemble those observed in humans22. Surprisingly, even though ApoE/LDLR−/− mice develop intensive 
coronary atherosclerosis and some authors report higher susceptibility of their hearts to hypoxic stress23,24, no 
reports published so far provide evidence of impaired cardiac function in ApoE/LDLR−/− mice25. Furthermore, 
there are no data in the literature regarding exercise capacity and cardiac haemodynamic response to exercise 
in ApoE/LDLR−/− mice. Therefore, we examined whole body maximal oxygen uptake (V’O2max) and exercise 
running capacity, as well as NO- and PGI2-dependent function of the coronary circulation of female ApoE/
LDLR−/− vs C57BL6/J mice in relationship to atherosclerosis development. We also measured basal cardiac func-
tion and dobutamine-stimulated cardiac performance that mimics exercise-induced haemodynamic changes 
in 6–8-month old female ApoE/LDLR−/− mice with advanced atherosclerosis as compared with age-matched 
C57BL6/J mice.
Figure 1. Running performance in female ApoE/LDLR−/− mice and C57BL6/J mice. (A) Body mass, (B,C) 
whole body maximal oxygen consumption (V’O2max) during incremental test, (D) maximal velocity (vmax) 
and (E) maximal distance (DISTmax) in running incremental test in 3-month (3m) and 6–8-month (6-8m) old 
ApoE/LDLR−/− and C57BL6/J mice. Statistical analysis was performed using two-sided t-test or non-parametric 
Mann-Whitney test depending on the results of D’Agostino and Pearson omnibus normality test. *indicates 
statistically significant difference between C57BL6/J and ApoE/LDLR−/− mice, #indicates statistically significant 
age-dependent difference within the strain. *,#P < 0.05, ##P < 0.01, ***,###P < 0.001; n = 16–20 for 3-month old 
C57BL6/J mice, n = 16–19 for 3-month old ApoE/LDLR−/− mice, n = 9–11 for 6–8-month old C57BL6/J mice 
and n = 11 for 6–8-month old ApoE/LDLR−/− mice. Data are presented as the mean ± SEM.
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Results
Exercise capacity of female ApoE/LDLR−/− and C57BL6/J mice. To measure effects of atherosclero-
sis development on exercise capacity of female ApoE/LDLR−/− mice we measured whole body maximal oxygen 
consumption (V’O2max), maximal velocity (vmax) achieved and maximal distance (DISTmax) covered during incre-
mental test for V’O2max measurement by young 3-month old female ApoE/LDLR−/− mice with early atheroscle-
rosis and older 6–8-month old female ApoE/LDLR−/− mice with advanced atherosclerosis26 as compared with 
age-matched control C57BL6/J mice.
Body mass of young female ApoE/LDLR−/− mice was higher than control C57BL6/J mice while for older 
female ApoE/LDLR−/− and C57BL6/J mice we found the opposite (Fig. 1A) and it increased with age in both 
mouse strains. Therefore, the data regarding V’O2max are presented both in absolute (Fig. 1B) and relative values 
(Fig. 1C). There was no difference in V’O2max expressed in relative values between the mouse strains (Fig. 1C). 
However, when expressed in absolute values, changes in V’O2max reflected changes in body weight (please com-
pare Fig. 1A,B).
Surprisingly, maximal velocities (vmax) achieved by female ApoE/LDLR−/− were higher than for age-matched 
C57BL6/J mice (35.84 m·min−1 vs 22.8 ± 0.84 m·min−1, n = 19–20, P < 0.0001 for younger female ApoE/LDLR−/− 
and C57BL6/J mice, respectively, and 30.82 ± 1.12 m·min−1 vs 22.45 ± 0.97 m·min−1, n = 11, P < 0.0001 for older 
female ApoE/LDLR−/− and C57BL6/J mice, respectively) (Fig. 1D). Similarly, maximal distances (DISTmax) 
covered by female ApoE/LDLR−/− and C57BL6/J mice were higher for female ApoE/LDLR−/− mice than for 
age-matched C57BL6/J mice (509.2 ± 34.97 m vs 214.8 ± 0.8417.15 m, n = 19–20, P < 0.0001 for younger female 
ApoE/LDLR−/− and C57BL6/J mice, respectively, and 359.4 ± 22.9 m vs 195.9 ± 19.04 m, n = 11, P < 0.0001 
for older female ApoE/LDLR−/− and C57BL6/J mice, respectively) (Fig. 1E). Interestingly, vmax and DISTmax 
declined with age only in female ApoE/LDLR−/− mice but not in C57BL6/J mice (35.84 m·min−1 for younger 
vs 30.82 ± 1.12 m·min−1 for older female ApoE/LDLR−/− mice, n = 11− 19, P = 0.0118 and 509.2 ± 34.97 m for 
younger vs 359.4 ± 22.9 m for older female ApoE/LDLR−/− mice, n = 11, P = 0.0052, respectively) probably due 
to atherosclerosis progression (Fig. 1D,E).
Measurement of blood count revealed that both younger and older female ApoE/LDLR−/− mice had higher 
number of circulating erythrocytes when compared with age-matched C57BL6/J mice (Table 1). However, num-
ber of erythrocytes declined with age in female ApoE/LDLR−/− mice what corresponded with age-dependent 
decline in vmax and DISTmax covered by female ApoE/LDLR−/− mice in the incremental test for V’O2max measure-
ment (Fig. 1D,E).
NO- and PGI2-dependent function of coronary circulation in female ApoE/LDLR−/− and C57BL6/J 
mice. We previously showed that in mice, in contrast to humans27 and guinea pigs28, acetylcholine-induced 
response in coronary circulation was mediated mainly by prostacyclin (PGI2)29 whereas Bk-induced response was 
mediated to a large extent by NO. In this study we found that, in spite of age-dependent peripheral atherosclerosis 
progression described earlier26 and coronary atherosclerosis progression described in this paper, changes in cor-
onary flow induced by Bk (0.03, 0.1, 0.3, 1.0 nmol) in isolated hearts from female ApoE/LDLR−/− mice were not 
impaired compared with age-matched C57BL6/J mice (Fig. 2A–C). Moreover, the inhibitory effect of L-NAME 
on the changes in coronary flow after Bk in C57BL6/J and in female ApoE/LDLR−/− mice hearts was similar 
(Fig. 2D–F). Interestingly, SNAP and SNP-induced coronary flow responses were augmented in 2, 4 and 8-month 
old female ApoE/LDLR−/− mice compared with age-matched C57BL6/J mice (Fig. 3).
C57BL6/J 3m ApoE/LDLR−/− 3m C57BL6/J 6-8m ApoE/LDLR−/− 6-8m
WBC [K·μl−1] 1.77 ± 0.28 (n = 10) 3.66 ± 1.31 (n = 5)
1.80 ± 0.23 
(n = 7) 2.48 ± 0.47 (n = 5)
LYM% [%] 78.89 ± 0.5 (n = 9) 71.88 ± 3.42* (n = 5)
73.74 ± 2.61# 
(n = 8) 73.00 ± 1.93 (n = 5)
MON% [%] 5.98 ± 0.3 (n = 9) 8.72 ± 0.83* (n = 5) 6.49 ± 0.53 (n = 8) 7.32 ± 0.68 (n = 5)
GRA% [%] 15.13 ± 0.32 (n = 9) 19.26 ± 2.85 (n = 5)
19.77 ± 2.57 
(n = 7) 19.68 ± 2.07 (n = 5)
RBC [M·μl−1] 10.36 ± 0.12 (n = 10)
11.51 ± 0.019*** 
(n = 5)
9.85 ± 0.38 
(n = 8)
10.83 ± 0.18*## 
(n = 6)
HGB [g·dL−1] 15.08 ± 0.26 (n = 10) 17.14 ± 0.14** (n = 5)
14.42 ± 0.49 
(n = 5) 15.28 ± 0.42
# (n = 4)
HCT [%] 54.61 ± 0.65 (n = 10) 63.48 ± 0.31** (n = 5)
52.30 ± 1.49 
(n = 8)
57.13 ± 1.46*## 
(n = 6)
PLT [K·μl−1] 902 ± 97.09 (n = 10) 895.4 ± 35.27 (n = 5)
1202 ± 67.88# 
(n = 7) 1089 ± 62.90
# (n = 6)
Table 1.  Blood count. WBC, white blood cells (LYM% (% of lymphocytes), MON% (% of monocytes), GRA% 
(% of granulocytes); RBC, red blood cells; HGB, haemoglobin; HCT, haematocrit; PLT, platelets count in young 
3-month old (3m) and older 6-8-month old (6-8m) C57BL6/J and ApoE/LDLR−/− mice. Statistical analysis was 
performed using Mann-Whitney test based on the results of D’Agostino and Pearson omnibus normality test. 
Data are presented as mean ± SEM. *indicates statistically significant difference between female C57BL6/J and 
ApoE/LDLR−/− mice, #indicates statistically significant age-dependent difference within the strain. *,#P < 0.05, 
**,##P < 0.01, ***P < 0.001.
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ACh-induced coronary flow response in 2, 4 and 8-month old female ApoE/LDLR−/− mice was not impaired 
(Fig. 4A), but ACh-induced 6-keto-PGF1α release into cardiac effluent increased (18.18 ± 12.58 mg·ml−1 .ml·min
−1 for 8-month old female ApoE/LDLR−/− mice, n = 11, compared to 4.99 ± 2.65 mg·ml−1.ml·min−1 for controls, 
n = 15, P < 0.05, Fig. 4B). It is worth to note that 6-keto-PGF1α release into cardiac effluent tended to be higher 
also for 2 and 4-month old female ApoE/LDLR−/− mice compared with control mice but the difference did not 
reach statistical significance. Basal 6-keto-PGF1α production in the hearts of female ApoE/LDLR−/− mice was 
also increased (238.6 ± 193.10 mg·ml−1.ml·min−1 for 8 months old female ApoE/LDLR−/− mice, n = 9, compared 
to 41.3 ± 17.02 mg·ml−1·ml·min−1 for controls, n = 11, P < 0.05) (Fig. 4C) and the difference in PGI2 production 
between female ApoE/LDLR−/− and C57BL6/J mice was abolished by COX-2 selective inhibitor, rofecoxib.
Since there was no statistically significant difference in Ach—induced changes in coronary flow, Ach—
induced changes in 6-keto-PGF1α release and changes in 6-keto-PGF1α release (basal and after rofecoxib treat-
ment) between 2, 4 and 8-month old C57BL6/J mice, the results for C57BL6/J mice were averaged.
Atherosclerotic lesions in coronary arteries of female ApoE/LDLR−/− mice. Histological analysis 
of atherosclerotic plaques in coronary circulation of 2, 4 and 6–8 month old female ApoE/LDLR−/− mice revealed 
that in initial parts of large coronary arteries branching from the aorta (proximal) age-related development of 
Figure 2. Bk–induced vasodilation responses in the coronary circulation of isolated heart in female 
ApoE/LDLR−/− mice. (A–C) Preservation of coronary flow responses evoked by Bk in the isolated hearts of 
2, 4 and 8-month old ApoE/LDLR−/− mice compared with age-matched C57BL6/J mice; n = 11 for 2-month 
old C57BL6/J mice, n = 13 for 2-month old ApoE/LDLR−/− mice, n = 14 for 4-month old C57BL6/J mice and 
n = 10 for 4-month old ApoE/LDLR−/− mice, n = 9 for 8-month old C57BL6/J mice and n = 18 for 8-month old 
ApoE/LDLR−/− mice. (D–F) NO-dependent part of coronary flow responses evoked by Bk in the isolated heart 
of ApoE/LDLR−/− mice compared with controls subjected to L-NAME (500 μM) treatment; n = 6 for 2-month 
old C57BL6/J mice, n = 6 for 2-month old ApoE/LDLR−/− mice, n = 7 for 4-month old C57BL6/J mice and 
n = 8 for 4-month old ApoE/LDLR−/− mice, n = 5 for 8-month old C57BL6/J mice and n = 8 for 8-month old 
ApoE/LDLR−/− mice. Statistical analysis was performed using t-test or non-parametric Mann-Whitney test, 
when assumptions were not completed. Data are presented as the mean ± SEM.
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atherosclerotic lesions was found (A and B, D and E, G and H, respectively) whereas small intramuscular coro-
nary arteries (distal) (Fig. 5C,F,I) displayed advanced atherosclerotic lesions largely occluding the vessel lumen. 
The middle parts of the coronary arteries were less affected (results not shown).
Cardiac performance at rest and under dobutamine stimulation in female ApoE/LDLR−/− 
and C57BL6/J mice. Basal left ventricle function including fractional area change (FAC), end systolic 
and end diastolic volume (ESV, EDV) and filling rate (FR) were not changed in 6–8-month old female ApoE/
LDLR−/− mice compared to age-matched C57BL6/J mice (P < 0.05, Fig. 6B,C,D,F). The only difference was that 
the heart rate was accelerated in C57BL6/J mice and basal ejection rate was higher in female ApoE/LDLR−/− 
mice (P < 0.05, Fig. 6A,E, respectively). Not only was basal cardiac function not compromised in female ApoE/
LDLR−/− mice as compared to age-matched C57BL6/J mice but also response to dobutamine stress was fully pre-
served. As shown in Fig. 6, dobutamine stimulation at low (0.5 mg·kg−1) and high dose (2 mg·kg−1) demonstrated 
fully preserved, inotropic and lusitropic response in female ApoE/LDLR−/− mice. In fact, the increase in FAC 
(from basal 0.67 ± 0.03 to 0.75 ± 0.06 and from 0.68 ± 0.11 to 0.82 ± 0.04 for controls vs. female ApoE/LDLR−/− 
mice respectively, P < 0.05, Fig. 6B–D) and decrease in ESA (from 3.49 ± 0.53 to 2.27 ± 0.81 and from 3.43± 1.51 
to 1.55 ± 0.53 for controls vs. female ApoE/LDLR−/− mice respectively, P < 0.05) and EDA (from 10.63 ± 0.9 
to 8.85 ± 1.31 and from 10.75 ± 1.38 to 8.39 ± 0.67 for controls vs. female ApoE/LDLR−/− mice respectively, 
Figure 3. SNAP and SNP–induced vasodilation responses in the coronary circulation of isolated heart in 
female ApoE/LDLR−/− mice. (A–C) Up-regulation of SNAP-induced coronary flow response in the isolated 
hearts of in 2, 4 and 8-month old ApoE/LDLR−/− mice compared with age-matched C57BL6/J mice; n = 12 
for 2-month old C57BL6/J mice, n = 7 for 2-month old ApoE/LDLR−/− mice, n = 6 for 4-month old C57BL6/J 
mice and n = 9 for 4-month old ApoE/LDLR−/− mice, n = 7 for 8-month old C57BL6/J mice and n = 13 for 
8-month old ApoE/LDLR−/− mice. (D–F) SNP-induced coronary flow response in isolated hearts from ApoE/
LDLR−/− mice compared with age-matched C57BL6/J mice; n = 7 for 2-month old C57BL6/J mice, n = 14 for 
2-month old ApoE/LDLR−/− mice, n = 5 for 4-month old C57BL6/J mice and n = 14 for 4-month old ApoE/
LDLR−/− mice, n = 10 for 8-month old C57BL6/J mice and n = 15 for 8-month old ApoE/LDLR−/− mice. 
Statistical analysis was performed using t-test or non-parametric Mann-Whitney test, when assumptions were 
not completed. Data are presented as the mean ± SEM.
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Figure 4. PGI2-dependent coronary vasodilation in the coronary circulation of isolated heart in female 
ApoE/LDLR−/− mice. (A) PGI2-dependent coronary flow response evoked by ACh (0.3 nmol) in isolated 
hearts of ApoE/LDLR−/− mice compared with control C57BL6/J mice. Since there was no statistically significant 
difference in Ach—induced changes in coronary blood flow between 2, 4 and 8-month old C57BL6/J mice, 
the results for C57BL6/J mice were averaged; n = 25 for C57BL6/J mice, n = 23 for 2-month old ApoE/
LDLR−/− mice, n = 16 for 4-month old ApoE/LDLR−/− mice, n = 22 for 8-month old ApoE/LDLR−/− mice. (B) 
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P < 0.05) were all comparable for female ApoE/LDLR−/− and age-matched C57BL6/J mice. In contrast, chrono-
tropic reserve was observed only in female ApoE/LDLR−/− mice (P < 0.05, not significantly, Fig. 6A). No reserve 
in ejection rate was observed in female ApoE/LDLR−/− mice, however their basal ejection rate was higher than in 
C57BL6/J mice (3.91 ± 0.68 for female ApoE/LDLR−/− mice as regards 3.35 ± 0.46 for controls, P < 0.05, Fig. 6E). 
Both groups responded similarly as regards filling rate showing no changes under dobutamine stress (P < 0.05, 
Fig. 6F).
Discussion
In this study we characterized whole body maximal oxygen uptake (V’O2max), exercise capacity and NO- and 
PGI2-dependent coronary endothelial function of female ApoE/LDLR−/− mice with respect to age-related 
peripheral atherosclerosis progression described elsewhere26 and age-related coronary atherosclerosis progres-
sion shown here. We also characterized cardiac haemodynamic response to dobutamine-induced stress in 6–8 
month old female ApoE/LDLR−/− mice with advanced coronary atherosclerosis in comparison with age-matched 
C57BL6/J mice. Surprisingly, we found that V’O2max considered a key index of cardio-respiratory capacity and 
running exercise capacity of female ApoE/LDLR−/− mice were preserved irrespective of atherosclerosis pro-
gression (Fig. 1). Moreover, both younger (3-month old) female ApoE/LDLR−/− mice and older (6–8-month 
old) female ApoE/LDLR−/− mice with early and advanced peripheral (as reported earlier26) and early and 
advanced coronary (as shown here) atherosclerosis achieved higher velocities and covered longer distances than 
age-matched C57BL6/J mice (Fig. 1D,E). Excellent running exercise capacity of female ApoE/LDLR−/− mice 
was associated with preserved NO-dependent function of coronary circulation (Fig. 2) and increased COX-
2-dependent PGI2 production (Fig. 4C). Moreover, cardiac performance at rest as well as its inotropic and 
lusitropic reserve were well preserved in 6–8-month old female ApoE/LDLR−/− mice (Fig. 6) with advanced 
coronary atherosclerosis (Fig. 5G–I) compared with age-matched C57BL6/J mice as evidenced by similar FAC, 
and slice-derived ESV and EDV in basal conditions as well as in response to dobutamine. Altogether, the present 
work demonstrated that development of atherosclerosis did not compromise V’O2max of female ApoE/LDLR−/− 
mice and did not influence their cardiac function even at the advanced stage of atherosclerosis with advanced 
atherosclerotic plaques in the coronary circulation and even during stress conditions. Running exercise capacity 
of 6–8-month old female ApoE/LDLR−/− mice was only slightly lower than in young female ApoE/LDLR−/− mice 
(Fig. 1D,E). Nevertheless, it was still better than in age-matched C57BL6/J mice. We claim that robust com-
pensatory mechanisms in coronary circulation, including increased vascular responsiveness to NO (Fig. 3) and 
increased generation of PGI2 (Fig. 4B,C) that are triggered in the early phase of atherosclerosis development, 
could, at least partly, account for preserved V’O2max and running exercise capacity of female ApoE/LDLR−/− mice 
as well as their full cardiac adaptation to exercise occurring even at the stage of advanced atherosclerosis at the 
age of 6–8 months.
Given that it is widely known that atherosclerosis progression severely impairs cardiac reserve and exercise 
capacity in humans4–6 and in atherosclerotic ApoE−/− mice of both genders11,13,14,17, our results regarding V’O2max, 
running exercise capacity and cardiac function of female ApoE/LDLR−/− mice are surprising. Indeed, exercise 
capacity of female ApoE/LDLR−/− mice was preserved despite peripheral (as reported previously26) and coronary 
(Fig. 5) atherosclerosis progression what could be a factor that could limit their exercise capacity30. These results 
can be only explained by important compensatory mechanisms triggered by double knockout of ApoE and Ldlr 
genes that preserved cardiac haemodynamic response to exercise of female ApoE/LDLR−/− mice (Fig. 6) and 
assured sufficient adaptation of blood flow and oxygen delivery to their cardiac muscle during exercise which is 
the major determinant of V’O2max (for review see31). These compensatory mechanisms could be, at least partly, 
associated with estrogens known to exert cardioprotective and vasoprotective effects. In fact, it was shown that in 
female atherosclerotic LDLR−/− mice estrogens up-regulate cyclooxygenase 2 (COX-2) –derived production of 
PGI2 via estrogen receptor subtype alpha32.
It is also worth noting that oxygen extraction ratio within coronary circulation is already nearly maximal at 
rest and, thus, the major mechanism involved in increasing oxygen delivery during exercise is based on coronary 
vasodilation (and increased coronary blood flow), while in the skeletal muscles an increase in oxygen delivery to 
working muscles is brought about by an increase in its extraction ratio and recruitment of capillaries, as well as 
increased blood flow31. Considering this, it is the coronary and but not the skeletal muscle circulation that rep-
resents a locus minoris resistantiae in the regulation of V’O2max and exercise capacity. Accordingly, compensatory 
mechanisms aimed to preserve V’O2max in female ApoE/LDLR−/− mice should be, first of all, present within the 
ACh-induced 6-keto-PGF1α release in isolated heart from ApoE/LDLR−/− mice compared with age-matched 
C57BL6/J mice. Since there was no statistically significant difference in Ach—induced changes of 6-keto-
PGF1α release between 2, 4 and 8-month old C57BL6/J mice, the results for C57BL6/J mice were averaged; 
n = 15 for C57BL6/J mice, n = 7 for 2-month old ApoE/LDLR−/− mice, n = 9 for 4-month old ApoE/LDLR−/− 
mice, n = 11 for 8-month old ApoE/LDLR−/− mice. (C) Effects of COX-2 inhibitor (rofecoxib, 10 μM) on 
basal 6-keto-PGF1α production in the isolated heart of ApoE/LDLR−/− mice. Since there was no statistically 
significant difference in changes of 6-keto-PGF1α release between 2, 4 and 8-month old C57BL6/J mice (basal 
and after rofecoxib treatment), the results for C57BL6/J mice were averaged; n = 11 and 5 for C57BL6/J mice, 
n = 8 and 6 for 2-month old ApoE/LDLR−/− mice, n = 9 and 6 for 4-month old ApoE/LDLR−/− mice, n = 9 
and 6 for 8-month old ApoE/LDLR−/− mice with respect to basal and after-rofecoxib 6-keto-PGF1α release. 
Statistical analysis was performed using t-test or non-parametric Mann-Whitney test (if the assumptions were 
not completed). *indicates P < 0.05 for ApoE/LDLR−/− vs. control mice. #indicates P < 0.05 with rofecoxib vs. 
without. Data are presented as the mean ± SEM.
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coronary circulation to preserve cardiac haemodynamic response to exercise. Indeed, our results fully support 
this assumption. In line with fully preserved basal cardiac function and stress response to dobutamine (Fig. 6), 
NO- and PGI2-dependent function of coronary circulation in female ApoE/LDLR−/− mice was not compro-
mised (Figs 2,3 and 4). On the contrary, clear-cut compensatory mechanisms in these mice were detected such 
as increased COX-2-dependent basal PGI2 production, increased COX-1-dependent PGI2 release in response 
to ACh as well as increased coronary vessel responsiveness to exogenous NO most likely linked to upregulation 
of soluble guanylate cyclase (sGC) activity in coronary vessels. Interestingly, these mechanisms were already 
evident in hearts of female ApoE/LDLR−/− mice as early as at two months of age, suggesting that these com-
pensatory mechanisms of coronary circulation are triggered before peripheral atherosclerotic plaques develop-
ment26 and are probably induced by early coronary atherosclerosis (Fig. 5A–C). Considering vasoprotective and 
anti-atherosclerotic activity of NO-sGC and COX-2-PGI2 pathways, it is tempting to speculate that these com-
pensatory changes within coronary circulation could mitigate the development of symptomatic ischaemic heart 
disease in female ApoE/LDLR−/− mice and explain why their cardiac function was not compromised (Fig. 6) 
despite extensive coronary atherosclerosis at the age of 6–8 months (Fig. 5G–I).
To counteract detrimental results of peripheral endothelial dysfunction in female ApoE/LDLR−/− mice, 
compensatory mechanisms induced by atherosclerosis also developed within peripheral circulation26. 
Namely, the cyclooxygenase-2 (COX-2)/PGI2 pathway was upregulated in the aorta of female ApoE/LDLR−/− 
mice as early as at two months of age and remained elevated in older animals. Although we did not analyse 
Figure 5. Coronary atherosclerosis in coronary arteries of female ApoE/LDLR−/− mice. Large coronary 
arteries with atherosclerotic plaques in 2-month old (A), 4-month old (D) and 6–8-month old (G) female 
ApoE/LDLR−/− mice and their lipid components ((B,E,H), respectively); small atherosclerotic lesions are only 
occasionally found in large coronary arteries of 2-month old ApoE/LDLR−/− mice (A,B) but become evident in 
older mice (D,E,G,H) (white arrows). The lumen of small intramuscular coronary arteries of 2, 4 and 6–8month 
old ApoE/LDLR−/− mice ((C,F,I), respectively) is almost completely occluded by atherosclerotic plaque. OMSB 
staining was used to depict the morphology of atherosclerotic plaques (A,D,G) and ORO was used to visualise 
significant lipid deposits within the plaques (B,C,E,F,H,I). Magnification 400×.
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Figure 6. Cardiac reserve for low (0.5 mg·kg−1) and high (2.0 mg·kg−1) dose of dobutamine in female ApoE/
LDLR−/− mice. Dobutamine stress test uncovered well-preserved cardiac reserve in ApoE/LDLR−/− mice. 
*indicates statistical significance in comparison of the ApoE/LDLR−/− and the control mice at basal conditions 
(P < 0.05, t-test; n = 7 in each group), whereas changes after dobutamine were marked as + for comparisons 
between the given dose of dobutamine (low or high) and the basal condition, and as # for comparisons between 
the high and low dose (P < 0.05, ANOVA and Tukey post-hoc test); n = 7–8 for C57BL6/J mice and 6 for ApoE/
LDLR−/− mice. Data are presented as the mean ± SEM.
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endothelium-dependent regulation of blood flow in skeletal muscles, it could well be that exercise-induced 
increase in blood flow in skeletal muscles was also preserved due to compensatory mechanisms triggered by 
NO-deficiency in female ApoE/LDLR−/− mice.
The mechanisms controlling coronary and muscle blood flow during exercise are not entirely understood 
and involve multiple endothelium-dependent vasodilatory pathways compensating one another. NO, PGI2 and 
RBC-derived ATP were claimed to be the major mediators involved31. It is widely known that NO is an important 
coronary and peripheral vasodilator during exercise33. However, in view of the available data, NO action alone 
could not explain the huge exercise-induced increase in skeletal muscles34 and coronary blood flow35. There is 
growing body of evidence that exercise-induced PGI2 might play an important role in regulation of coronary 
and muscle blood flow. It was demonstrated that the magnitude of exercise-induced PGI2 release correlated pos-
itively with V’O2max in healthy humans36, while plasma nitrite concentration did not increase even upon vigorous 
exercise (for review see)31. Moreover, training-induced increase in V’O2max was also associated with increased 
exercise-induced PGI2 release37. Furthermore, administration of PGI2 to patients with pulmonary hyperten-
sion increased their exercise capacity38. Extrapolating from human studies, increased PGI2 release into coronary 
(Fig. 4C) and peripheral26 circulation of female ApoE/LDLR−/− mice could account for their preserved V’O2max 
(Fig. 1B,C) and, paradoxically better running exercise capacity (Fig. 1D,E) as well as their preserved basal and 
dobutamine-stimulated cardiac function (Fig. 6).
Interestingly, there was also a higher number of circulating erythrocytes in female ApoE/LDLR−/− mice 
compared with age-matched C57BL6/J control mice (Table 1). This could represent yet another mechanism that 
assured adequate oxygen supply to working tissues. Apart from oxygen transport, haemoglobin inside red blood 
cells reduces plasma nitrite (NO2−) to NO in hypoxic conditions that is subsequently released and contributes 
to local vasodilation31,39–41. When oxygen tension decreases within coronary microvasculature, red blood cells 
also release ATP which is a factor increasing coronary blood flow during exercise42. Increased number of circu-
lating erythrocytes in female ApoE/LDLR−/− mice points to increased erythropoesis in these animals (probably 
to counteract hypoxia). Indeed, erythropoietin production was shown to be higher in mice with atherosclerosis43 
and it activated mitochondrial biogenesis to couple red cell mass to mitochondrial mass in the heart44. Therefore, 
even though we claim that upregulation of PGI2-dependent pathways within the coronary circulation(Fig. 4B,C) 
seems to represent the major compensatory mechanism in female ApoE/LDLR−/− mice that contribute to their 
cardiac haemodynamic adaptation to exercise, many other possible mechanisms (i.e. enhanced RBC-driven 
ATP release, erythropoietin-mediated mechanisms, mitochondrial biogenesis in the heart, and shift in sub-
strate metabolism in heart and skeletal muscles) could also contribute to their extraordinary exercise capacity. 
Moreover, higher maximal running velocity found in female ApoE/LDLR−/− mice compared with age-matched 
C57BL6/J mice was accompanied by similar or even higher V’O2max in female ApoE/LDLR−/− mice (compare 
Fig. 1D,B,C, respectively). This could be explained by higher muscle mechanical efficiency (for overview see45) 
in female ApoE/LDLR−/− mice, similar to in the trained vs. untrained humans (see46) and/or by higher capacity 
of anaerobic glycolysis and grater fatigue resistance in the locomotor muscles of the female ApoE/LDLR−/− mice 
allowing them to maintain the exercise long after reaching their V’O2max. Indeed, compensatory mechanisms 
might operate also in the skeletal muscles of female ApoE/LDLR−/− mice enabling them to run on the treadmill 
much better than their age-matched C57BL6/J counterparts with similar V’O2max.
To conclude, we claim that robust compensatory mechanisms in the hearts of female ApoE/LDLR−/− mice 
including increased vascular responsiveness to NO and increased generation of PGI2 could, at least partly, explain 
preserved whole body V’O2max as well as full cardiac adaptation to exercise of female ApoE/LDLR−/− mice despite 
peripheral and coronary atherosclerosis progression. Our results demonstrate surprisingly efficient adaptive 
mechanisms in the coronary circulation in female ApoE/LDLR−/− mice which when understood better, may be 
exploited therapeutically to limit impending impairment of cardiac output and the risk of perfusion deficit of the 
heart with coronary atherosclerosis.
Methods
Animals. ApoE/LDLR−/− female mice20 were obtained from Jackson Lab (USA) and bred in-house. To 
asses exercise capacity and in vivo cardiac reserve, we used 6–8-month old female ApoE/LDLR−/−(n = 22) with 
advanced atherosclerosis and their age-matched wild-type female C57BL6/J (n = 26) littermates obtained from 
Charles River (Germany)47. For isolated hearts studies, 2–8 month old (2 months old, n = 79; 4 months old, 
n = 76; and 8 months old, n = 95) female ApoE/LDLR−/− mice were used and compared to the controls (2–8 
months C57BL6/J, n = 113). Mice were housed 3–5 per cage, in a temperature-controlled environment (22–25 °C) 
maintained on a 12 hour light/day cycle and given unlimited access to food (standard chow diet Altromin 1324 
TPF (Altromin, Germany)) and water. All experimental protocols were conducted according to the Guidelines 
for Animal Care and Treatment of the European Union and approved by the First Local Ethical Committee 
on Animal Testing at the Jagiellonian University in Krakow (approvals No. 49/2009, 53/2009, 27/2014) and the 
Second Local Ethical Committee on Animal Testing at the Institute of Pharmacology of the Polish Academy of 
Sciences in Krakow (approval No. 914/2012).
Incremental exercise for V’O2max measurement. All animals were acclimatized to the closed treadmill 
for metabolic measurements (Columbus Instruments, Columbus, OH, USA) for three days before the experi-
ment. Randomly selected mice from all groups (n > 9) underwent maximal incremental testing with measure-
ment of respiratory metabolic performance according to the protocol described before48. Briefly, mice were run 
on a single-line metabolic treadmill equipped with a shock grid at 0°. The exercise protocol started at 5 m·min−1 
and the speed was increased by 4 m·min−1 every 3 min until exhaustion. Data on whole body oxygen consump-
tion (V’O2) were collected.
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Blood collection. Mice were anesthetized by sodium pentobarbital/pentobarbital (5:1) overdose (1 ml·kg−1, 
intraperitoneally) and the rib cage was cut along the sides to expose the heart. Blood was collected from the right 
ventricle into a syringe with nadroparin (10 U·ml−1) and the blood count was performed at animal blood counter 
Vet abc (Horiba Medical, France).
Measurements in isolated perfused heart. The detailed technique of isolated heart perfusion to study 
alterations in coronary flow in mouse model according to Langendorff is described elsewhere49. The animals 
were anesthetized with mixture of ketamine (100 mg·kg−1) and xylazine (10 mg·kg−1). The hearts were precisely 
excised from the animal body and placed in ice-cold Krebs-Hanseleit bicarbonate buffer, where extraneous tissues 
were quickly removed. The aorta was attached to the prepared aortic cannula and isolated hearts were retrograde 
perfused with Krebs-Hanseleit buffer under 80 mmHg pressure and at 37 °C. It took approximately less than 
30 seconds to mount the heart for Langendorff perfusion (hearts that required longer time for mounting were 
discarded from analysis). Coronary flow (CF) during the perfusion time was monitored by ultrasonic flow meter 
(Transit Time Flowmeter TTFM, HSE-Harvard and Transonic System Inc., USA) and flow measurements were 
displayed throughout the experiment at all time points. Two electrodes were placed on the right atrium of the 
heart model generating 400 impulses per minute. To characterize the responsiveness of coronary vessels to vas-
odilation several drugs were given at the volume of 10 μL each: bradykinin (Bk: NO – dependent, in 2 (n = 10), 
4 (n = 10) and 8 (n = 13) months old female ApoE/LDLR−/− mice and 2–4 controls (n = 16)), Acetylcholine 
(ACh: PGI2 – dependent, in 2 (n = 23), 4 (n = 16) and 8 (n = 22) months old female ApoE/LDLR−/− mice and 
2–4 controls(n = 25)) as well as two exogenous, endothelium-independent NO – donors with different mecha-
nism of NO release sodium nitroprusside (SNP in 2 (n = 7), 4 (n = 8) and 8 (n = 12) months old female ApoE/
LDLR−/− mice and 2–4 months old controls (n = 14) and S-Nitroso-N-acetylpenicillamine (SNAP in 2 (n = 14), 
4 (n = 14) and 8 (n = 15) months old female ApoE/LDLR−/− mice and 2–4 months old controls (n = 16)). ACh 
(0.3 nmol) was injected as one bolus, whereas Bk, SNAP and SNP were injected as multiple doses (0.03; 0.1; 
0.3 and 1.0 nmol). To study the contribution of NOS and cyclooxygenase (COX) to the coronary flow response 
separately, the nonselective NO - synthase inhibitors, NG – nitro-L-arginine methyl ester (L-NAME 500 μM in 2 
(n = 6), 4 (n = 6) and 8 (n = 8) months old female ApoE/LDLR−/− mice and 2–4 months old controls (n = 16)) 
and COX-2 selective cyclooxygenase inhibitors – Rofecoxib, 10 μM (in 2 (n = 6), 4 (n = 6) and 8 (n = 6) months 
old female ApoE/LDLR−/− mice and 2–4 months old controls (n = 5) were used. After experiments all hearts 
were weighed and alterations in coronary flow were expressed in ml·min·g−1 of the wet ventricular weight. For 
determination of the concentration of the 6-keto-PGF1α in effluent from the coronary vessels, samples of the 
effluent (500 μl) were collected and stored at − 70 °C until analysed by commercially available enzyme immu-
noassay kits (Cayman Chemical Co, Ann Arbor, MI). 6-keto-PGF1α concentration was expressed in mg·l−1  
(or ng·ml−1) of coronary flow (ml·min−1).
Assessment of coronary atherosclerosis in coronary arteries. The hearts were dissected, embedded 
in the OCT compound (CellPath, Oxford, UK), and snap-frozen or fixed in 4% paraformaldehyde (pH 7.4), 
paraffin embedded and serially sectioned. Then, 10 μm thick serial cross-section slides of the heart were cut in 
the apex region, at the middle (at papillary muscle level) and upper part of the heart (aortic roots), to evaluate 
the coronary atherosclerosis in distal, intramuscular and proximal parts of coronary arteries. The sections were 
stained with the oil red-O for lipids detection in the atherosclerotic plaque or with the OMSB staining (Orceine 
with Martius, Scarlet and Blue) for histological characterisation. Photographs were acquired using the Carl Zeiss 
HmR monochromatic digital camera.
Cardiac performance. Cardiac function was assessed using cardiac magnetic resonance imaging (MRI) 
with a 9.4T Bruker BioSpec system (Bruker, Ettlingen, Germany) equipped with BFG-113/60-S gradient system 
and 36 mm 1H quadrature volume resonator. Physiological parameters were monitored and gated using Model 
1025 Monitoring and Gating System (SA Inc., Stony Brook, NY). Mice were measured under anesthesia main-
tained at 1.7% of isoflurane (Aerrane, Baxter) in a 1/2 oxygen/air mixture delivered via nose mask with monitor-
ing of ECG, respiration and body temperature (37 °C). MRI cine scans were acquired with retrospectively gated 
IntraGate FLASH 2D sequences with the following parameters: echo time 1.49 ms, repetition time 4.3 ms, flip 
angle 18°, number of repetitions 250, field of view 30 × 30 mm2, matrix 256 × 256, slice thickness 1.0 mm and 
reconstructed with IntraGate 1.2.b.2 macro (Bruker) to 60 frames per cardiac cycle. LV images were analysed 
using the Segment package17 (v.1.9 R2626, Medviso AB, Sweden) and papillary muscles were included in the cav-
ity volume. Single-slice volume was plotted against the time and used for regional cardiac functional parameters: 
end-diastolic/end-systolic volume (EDV/ESV), fractional area change (FAC), stroke area change (SAC) and LV 
filling and ejection rates (FR, ER normalized to the individual SAC and R–R values).
Statistical analysis. Statistical analyses were performed in GraphPad Prism Software (GraphPad Software, 
USA) and STATISTICA 10 software (Stat-Soft Inc., USA). Results from exercise performance test, body mass and 
blood count were analysed with two-sided t test or non-parametric Mann-Whitney test based on the results of 
D’Agostino and Pearson omnibus normality test. Results from in vivo basic cardiac performance as well as from 
isolated perfused hearts were analysed by the t-test for independent variables. If parametric tests assumptions 
were not fulfilled (normality of distributions and homogeneity of variance), non-parametric Mann-Whitney U 
test or Friedman test was used. For in vivo cardiac reserve assessment, a repeated-measures ANOVA followed by 
a Tukey post-hoc test was used. All data were presented as mean values ± SEM.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:24714 | DOI: 10.1038/srep24714
References
1. Jamkhande, P. G. et al. Therapeutic approaches to drug targets in atherosclerosis. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 
22, 179–90 (2014).
2. Tabas, I., Garcia-Cardena, G. & Owens, G. K. The cell biology of disease: Recent insights into the cellular biology of atherosclerosis. 
J. Cell Biol. 209, 13–22 (2015).
3. Benetos, A. et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am. J. 
Hypertens. 15, 1101–8 (2002).
4. Hamburg, N. M. & Balady, G. J. Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. 
Circulation 123, 87–97 (2011).
5. Regensteiner, J. G. Type 2 diabetes mellitus and cardiovascular exercise performance. Rev. Endocr. Metab. Disord. 5, 269–76 (2004).
6. Mark, D. B. & Lauer, M. S. Exercise capacity: the prognostic variable that doesn’t get enough respect. Circulation 108, 1534–6 (2003).
7. Mégnien, J.-L. & Simon, A. Exercise tolerance test for predicting coronary heart disease in asymptomatic individuals: A review. 
Atherosclerosis 205, 579–83 (2009).
8. Ramos, L. M. Cardiac diagnostic testing: what bedside nurses need to know. Crit. Care Nurse 34, 16–27, quiz 28 (2014).
9. Myers, J. et al. Supervision of exercise testing by nonphysicians: a scientific statement from the American Heart Association. 
Circulation 130, 1014–27 (2014).
10. Getz, G. S. & Reardon, C. A. Animal models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 1104–15 (2012).
11. Maxwell, A. J., Schauble, E., Bernstein, D. & Cooke, J. P. Limb blood flow during exercise is dependent on nitric oxide. Circulation 
98, 369–74 (1998).
12. Niebauer, J. et al. Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am. J. Physiol. 276, 
H1346–54 (1999).
13. Maxwell, A. J. et al. L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. J. Appl. 
Physiol. 90, 933–8 (2001).
14. Maxwell, A. J. et al. Hypercholesterolemia impairs exercise capacity in mice. Vasc. Med. 14, 249–57 (2009).
15. Hartley, C. J. et al. Hemodynamic changes in apolipoprotein E-knockout mice. Am. J. Physiol. Heart Circ. Physiol. 279, H2326–34 
(2000).
16. Wang, Y.-X. Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice. Neurobiol. 
Aging 26, 309–16 (2005).
17. Vincelette, J., Martin-McNulty, B., Vergona, R., Sullivan, M. E. & Wang, Y.-X. Reduced cardiac functional reserve in apolipoprotein 
E knockout mice. Transl. Res. 148, 30–6 (2006).
18. Lightfoot, J. T., Turner, M. J., Daves, M., Vordermark, A. & Kleeberger, S. R. Genetic influence on daily wheel running activity level. 
Physiol. Genomics 19, 270–6 (2004).
19. Murphy, M. O. B. The Role of Exercise in Polychlorinated Biphenyl Induced Cardiovascular Disease, PhD thesis, University of 
Kentucky (2014).
20. Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L. & Brown, M. S. The two-receptor model of lipoprotein clearance: tests of the 
hypothesis in ‘knockout’ mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. 
USA 91, 4431–5 (1994).
21. Yin, W. et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J. Lipid Res. 
53, 51–65 (2011).
22. Whitman, S. C. A practical approach to using mice in atherosclerosis research. Clin. Biochem. Rev. 25, 81–93 (2004).
23. Caligiuri, G., Levy, B., Pernow, J., Thorén, P. & Hansson, G. K. Myocardial infarction mediated by endothelin receptor signaling in 
hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 96, 6920–4 (1999).
24. Hemdahl, A.-L., Falk, E., Thorén, P. & Hansson, G. K. Thrombin inhibitor reduces myocardial infarction in apoE− /− × LDLR− /− 
mice. Am. J. Physiol. Heart Circ. Physiol. 287, H872–7 (2004).
25. Grönros, J., Wikström, J., Hägg, U., Wandt, B. & Gan, L. Proximal to middle left coronary artery flow velocity ratio, as assessed using 
color Doppler echocardiography, predicts coronary artery atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 26, 1126–31 
(2006).
26. Csányi, G. et al. Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice. Prostaglandins 
Other Lipid Mediat. 98, 107–15 (2012).
27. Nishikawa, Y. & Ogawa, S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J. Am. Coll. 
Cardiol. 29, 85–92 (1997).
28. Kozlovski, V. I., Lomnicka, M. & Chlopicki, S. Nebivovol and carvedilol induce NO-dependent coronary vasodilatation that is 
unlikely to be mediated by extracellular ATP in the isolated guinea pig heart. Pharmacol. Rep. 58 Suppl, 103–10 (2006).
29. Gwóźdź, P., Drelicharz, L., Kozlovski, V. I. & Chlopicki, S. Prostacyclin, but not nitric oxide, is the major mediator of acetylcholine-
induced vasodilatation in the isolated mouse heart. Pharmacol. Rep. 59, 545–52 (2007).
30. Patel, A. R. et al. Peripheral vascular endothelial function correlates with exercise capacity in women. Clin. Cardiol. 28, 433–6 
(2005).
31. Zoladz, J. A., Majerczak, J., Duda, K. & Chlopicki, S. Coronary and muscle blood flow during physical exercise in humans; 
heterogenic alliance. Pharmacol. Rep. 67, 719–27 (2015).
32. Egan, K. M. et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306, 1954–7 (2004).
33. Joyner, M. J. & Casey, D. P. Muscle blood flow, hypoxia, and hypoperfusion. J. Appl. Physiol. 116, 852–7 (2014).
34. Saltin, B. In search of a vasodilator: is ATP the answer? J. Physiol. 590, 5261–2 (2012).
35. Tune, J. D., Gorman, M. W. & Feigl, E. O. Matching coronary blood flow to myocardial oxygen consumption. J. Appl. Physiol. 97, 
404–15 (2004).
36. Zoladz, J. A., Majerczak, J., Duda, K. & Chłopicki, S. Exercise-induced prostacyclin release positively correlates with V’O2max in 
young healthy men. Physiol. Res. 58, 229–38 (2009).
37. Zoladz, J. A., Majerczak, J., Duda, K. & Chlopicki, S. Endurance training increases exercise-induced prostacyclin release in young, 
healthy men–relationship with V’O2max. Pharmacol. Rep. 62, 494–502 (2010).
38. Paramothayan, N. S., Lasserson, T. J., Wells, A. U. & Walters, E. H. Prostacyclin for pulmonary hypertension in adults. Cochrane 
database Syst. Rev. CD002994 doi: 10.1002/14651858.CD002994.pub2 (2005).
39. Gladwin, M. T. Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv. Exp. Med. Biol. 588, 189–205 
(2006).
40. Mairbäurl, H. Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells. Front. Physiol. 4, 332 
(2013).
41. Deonikar, P., Abu-Soud, H. M. & Kavdia, M. Computational analysis of nitric oxide biotransport to red blood cell in the presence of 
free hemoglobin and NO donor. Microvasc. Res. 95, 15–25 (2014).
42. Farias, M., Gorman, M. W., Savage, M. V. & Feigl, E. O. Plasma ATP during exercise: possible role in regulation of coronary blood 
flow. Am. J. Physiol. Heart Circ. Physiol. 288, H1586–90 (2005).
43. Arcasoy, M. O. Non-erythroid effects of erythropoietin. Haematologica 95, 1803–05 (2010).
44. Carraway, M. S. et al. Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the 
heart. Circ. Res. 106, 1722–30 (2010).
www.nature.com/scientificreports/
13Scientific RepoRts | 6:24714 | DOI: 10.1038/srep24714
45. Grassi, B., Rossiter, H. B. & Zoladz, J. A. Skeletal muscle fatigue and decreased efficiency: two sides of the same coin? Exerc. Sport Sci. 
Rev. 43, 75–83 (2015).
46. Majerczak, J. et al. Endurance training decreases the non-linearity in the oxygen uptake-power output relationship in humans. Exp. 
Physiol. 97, 386–99 (2012).
47. Vaillant, F. et al. Mouse strain differences in metabolic fluxes and function of ex vivo working hearts. Am. J. Physiol. Heart Circ. 
Physiol. 306, H78–87 (2014).
48. Wojewoda, M. et al. Running performance at high running velocities is impaired but V’O2max and peripheral endothelial function 
are preserved in IL-6−/− mice. PLoS One 9, e88333 (2014).
49. Chłopicki, S. & Gryglewski, R. J. The endothelium-dependent and the endothelium-independent vasodilators in the isolated, 
perfused guinea pig heart. J. Physiol. Pharmacol. 43, 353–65 (1992).
Acknowledgements
This research was supported by the European Union from the resources of the European Regional Development 
Fund under the Innovative Economy Programme (grant coordinated by JCET-UJ) No. POIG.01.01.02-00-069/09) 
and partially by the National Science Centre grant No DEC-2015/16/W/NZ4/00070.
Author Contributions
S.C. and J.A.Z. conceived the original idea and reviewed the manuscript. S.C., M.W. and U.T. designed 
experiments, M.W., U.T., P.G., T.S., M.J., A.O., K.J., A.J. and K.P. performed the experiments. R.K. provided 
experimental tools, M.W. and M.J. performed statistical analysis. M.W., U.T., S.C. and J.A.Z. wrote the manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Wojewoda, M. et al. Exercise capacity and cardiac hemodynamic response in female 
ApoE/LDLR−/− mice: a paradox of preserved V’O2max and exercise capacity despite coronary atherosclerosis. Sci. 
Rep. 6, 24714; doi: 10.1038/srep24714 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
